Inflammation has an important role in cancer development through various mechanisms. It has been shown that dysregulation of microRNAs (miRNAs) that function as oncogenes or tumor suppressors contributes to tumorigenesis. However, the relationship between inflammation and cancer-related miRNA expression in tumorigenesis has not yet been fully understood. Using K19-C2mE and Gan mouse models that develop gastritis and gastritis-associated tumors, respectively, we found that 21 miRNAs were upregulated, and that 29 miRNAs were downregulated in gastric tumors in an inflammation-dependent manner. Among these miRNAs, the expression of miR-7, a possible tumor suppressor, significantly decreased in both gastritis and gastric tumors. Moreover, the expression of miR-7 in human gastric cancer was inversely correlated with the levels of interleukin-1b and tumor necrosis factor-a, suggesting that miR-7 downregulation is related to the severity of inflammatory responses. In the normal mouse stomach, miR-7 expression was at a basal level in undifferentiated gastric epithelial cells, and was induced during differentiation. Moreover, transfection of a miR-7 precursor into gastric cancer cells suppressed cell proliferation and soft agar colony formation. These results suggest that suppression of miR-7 expression is important for maintaining the undifferentiated status of gastric epithelial cells, and thus contributes to gastric tumorigenesis. Although epigenetic changes were not found in the CpG islands around miR-7-1 of gastritis and gastric tumor cells, we found that activated macrophage-derived small molecule(s) (o3 kDa) are responsible for miR-7 repression in gastric cancer cells. Furthermore, the miR-7 expression level significantly decreased in the inflamed gastric mucosa of Helicobacter-infected mice, whereas it increased in the stomach of germfree K19-C2mE and Gan mice wherein inflammatory responses were suppressed.
Inflammation has an important role in cancer development through various mechanisms. It has been shown that dysregulation of microRNAs (miRNAs) that function as oncogenes or tumor suppressors contributes to tumorigenesis. However, the relationship between inflammation and cancer-related miRNA expression in tumorigenesis has not yet been fully understood. Using K19-C2mE and Gan mouse models that develop gastritis and gastritis-associated tumors, respectively, we found that 21 miRNAs were upregulated, and that 29 miRNAs were downregulated in gastric tumors in an inflammation-dependent manner. Among these miRNAs, the expression of miR-7, a possible tumor suppressor, significantly decreased in both gastritis and gastric tumors. Moreover, the expression of miR-7 in human gastric cancer was inversely correlated with the levels of interleukin-1b and tumor necrosis factor-a, suggesting that miR-7 downregulation is related to the severity of inflammatory responses. In the normal mouse stomach, miR-7 expression was at a basal level in undifferentiated gastric epithelial cells, and was induced during differentiation. Moreover, transfection of a miR-7 precursor into gastric cancer cells suppressed cell proliferation and soft agar colony formation. These results suggest that suppression of miR-7 expression is important for maintaining the undifferentiated status of gastric epithelial cells, and thus contributes to gastric tumorigenesis. Although epigenetic changes were not found in the CpG islands around miR-7-1 of gastritis and gastric tumor cells, we found that activated macrophage-derived small molecule(s) (o3 kDa) are responsible for miR-7 repression in gastric cancer cells. Furthermore, the miR-7 expression level significantly decreased in the inflamed gastric mucosa of Helicobacter-infected mice, whereas it increased in the stomach of germfree K19-C2mE and Gan mice wherein inflammatory responses were suppressed.
Taken together, these results indicate that downregulation of tumor suppressor miR-7 is a novel mechanism byIntroduction It has been established that inflammatory responses contribute to cancer development through various mechanisms (Coussens and Werb, 2002) . The expression of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for prostaglandin biosynthesis, has an important role in both inflammation and cancer (Wang and DuBois, 2010) . Using genetic mouse models, we previously demonstrated that induction of COX-2 and its downstream product, prostaglandin E 2 (PGE 2 ), is required for gastrointestinal tumorigenesis (Sonoshita et al., 2001; Oshima et al., 2006) . The COX-2/PGE 2 pathway, together with a bacterial infection, induces inflammatory responses in the stomach through the recruitment of macrophages, which promotes gastric tumorigenesis (Oshima et al., 2011) . However, it remains to be fully elucidated precisely how such inflammatory responses contribute to the promotion of gastric tumors.
MicroRNAs (miRNAs) are a class of single-stranded small noncoding RNAs that regulate gene expression by post-transcriptional interference of specific mRNAs (Ambros, 2004; Bartel, 2004) . Through their regulation of cancer-related gene expression, miRNAs can function as either oncogenes or tumor suppressors (EsquelaKerscher and Slack, 2006; Ventura and Jacks, 2009 ). Dysregulation of miRNAs in cancer has been shown to be associated with genomic/epigenetic alterations or transcriptional/post-transcriptional mechanisms (Di Leva and Croce, 2010) . Moreover, expression of several miRNAs, including oncogenic miRNAs, has been shown to be induced by inflammatory responses (Sonkoly and Pivarcsi, 2011) . For example, miR-155 is induced in macrophages by nuclear factorkB, interferon-b or Toll-like receptor signaling (O'Connell et al., 2007; Tili et al., 2007) , whereas miR-21 is induced by Stat3, a transcription factor activated by interleukin-6 (IL-6) (Iliopoulos et al., 2010) . On the other hand, the mechanism responsible for the downregulation of tumor-suppressor miRNA expression in the inflammatory microenvironment has not been fully understood.
Herein, we examined the expression of miRNAs in mouse models of gastritis and gastric tumors, which were developed in K19-C2mE and Gan mice, respectively (Oshima et al., 2004 (Oshima et al., , 2006 ). We found the expression level of miR-7 to significantly decrease in gastric tumors in an inflammation-dependent manner. It has been shown that miR-7 has a tumor-suppressor role in several cancers, including glioblastoma, breast cancer and lung cancer (Kefas et al., 2008; Reddy et al., 2008; Webster et al., 2009; Jiang et al., 2010; Saydam et al., 2011) . In this manuscript, we demonstrate that miR-7 is induced during the differentiation of normal gastric epithelial cells, and it also has a tumor-suppressor role in the stomach. These results suggest that downregulation of tumor suppressor miR-7 is one of the tumor-promoting mechanisms underlying the role of inflammation in gastric tumorigenesis.
Results

Inflammation-dependent dysregulation of miRNAs in gastric tumors
To examine whether miRNA expression is dysregulated in gastric tumors by inflammatory responses, we examined the miRNA expression profiles in wild-type mouse stomachs, K19-C2mE mouse gastritis and Gan mouse gastric tumors by a microarray analysis. In Gan mouse gastric tumors, 50 miRNAs were upregulated (42.0-fold), whereas 42 miRNAs were downregulated (o0.5-fold) compared with the wild-type mouse stomach level ( Figure 1a and Supplementary Table 1) . Notably, 21 and 29 miRNAs showed upregulation or downregulation, respectively, in both gastritis and gastric tumors. Therefore, it is possible that dysregulation of these miRNAs is caused by inflammatory responses.
We confirmed the results of the microarray analysis by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). In all, 10 miRNAs randomly selected from the upregulated and downregulated miRNAs (Figure 1a, boxed) showed the same dysregulation pattern in both gastritis and gastric tumors (Figure 1b) . Importantly, miR-155 and miR-21, which function as oncogenes (Volinia et al., 2006) were upregulated, whereas miR-145 and miR-7, which function as tumor suppressors (Kefas et al., 2008; Sachdeva et al., 2009) , were downregulated in both gastritis and gastric tumors (Figures 1a and b) . This suggests that inflammation can induce not only upregulation of oncogenic miRNAs but also downregulation of tumorsuppressor miRNAs.
We next picked up 74 miRNAs that were not dysregulated in K19-C2mE gastritis compared with the wild-type normal stomach (Supplementary Table 2 ). Among them, three miRNAs were upregulated in Gan mouse tumors compared with K19-C2mE gastritis tissue samples (42.0-fold), whereas three miRNA were downregulated (o0.5-fold) (Figure 1c) . It is possible that expression of these miRNAs is dysregulated by carcinogenesis-specific mechanisms.
Induction of miR-7 during differentiation of gastric epithelial cells We further examined the expression of miR-7, because its role(s) in the normal stomach and gastric cancer have never been examined. Gastric glands were isolated from the stomachs of the respective mouse models, and the miR-7 expression was examined by real-time RT-PCR. Notably, miR-7 levels were significantly lower in epithelial cells of K19-C2mE gastritis tissues and Gan mouse tumors compared with the wild-type mouse stomach (Figure 2a ), indicating that miR-7 is predominantly expressed in epithelial cells in an inflammationdependent manner.
When primary cultured gastric epithelial cells were passaged and maintained for 6 days, the cell morphology appeared to be differentiated, with enlarged and mucin-containing cytoplasm (Figure 2b) . Consistently, the expression of differentiation markers, Muc6 and Muc5AC, was elevated on day 6, whereas the expression of the Wnt target gene, Sox9, decreased (Figure 2c ). These results indicate that cultured gastric epithelial cells underwent differentiation through passage and 6-day culture. Importantly, the miR-7 expression level increased significantly on day 6 to 6.5-fold, compared with the level observed on day 2.
We next examined the miR-7 level in the stomach during development. The expression level of miR-7 in the stomach increased significantly in 14-day-old and adult mice, to 46-fold of that in E15 embryos (Figure 2d ). Conversely, expression of CD44, one of the Wnt target genes, decreased significantly during development. We confirmed by an immunohistochemistry that most epithelial cells in the gastric mucosa were Ki-67 positive on days 0 and 7, whereas proliferating cells were limited to the gland neck on day 14 and in adult mice (Figure 2e) . Accordingly, the ratio of undifferentiated epithelial cells decreased during development. Taken together, these results indicate that miR-7 expression is induced in gastric epithelial cells during differentiation.
Tumor-suppressor role of miR-7 in gastric cancer development We next examined miR-7 levels in human gastric cancers by real-time RT-PCR. The expression of miR-7 was downregulated in 18 out of 28 human gastric cancer tissue samples (64%) compared with paired non-tumor stomach tissue samples (Figure 3a) , suggesting that miR-7 has a tumor-suppressor role in a subpopulation of gastric cancers. We next examined the expression level of IL-1b and tumor necrosis factor (TNF)-a, major proinflammatory cytokines, and compared them with the miR-7 level. Importantly, expression levels of miR-7 were inversely correlated with those of IL-1b or TNF-a, suggesting that the downregulation of miR-7 is related to the severity of inflammatory responses (Figure 3b ). We also found that miR-7 was markedly downregulated in four out of nine gastric cancer cells lines (Figure 3c ).
To examine the tumor-suppressor role of miR-7 in gastric tumorigenesis, we transfected the precursor of miR-7, pre-miR-7, into AZ-521 and Kato-III gastric cancer cells and examined their proliferation and soft agar colony formation. We confirmed that premiR-7 transfection into reporter vector-transfected cells resulted in a significant decrease in luciferase activity, indicating an increase of mature miR-7 level (Supplementary Figure 1) . Transfection of pre-miR-7 Repression of miR-7 by inflammation D Kong et al significantly decreased cell proliferation in both cell lines compared with control vector-transfected cells ( Figure 3d ). Moreover, pre-miR-7 transfection significantly suppressed soft agar colony formation in both cell lines (Figures 3e and f) . These results strongly suggest that miR-7 has a tumor-suppressor role in gastric cancer development.
Repression of miR-7 in gastric cancer cells by macrophage-derived factor(s)
We detected primary (pri)-miR-7-1, pri-miR-7-2 and pri-miR-7b in the mouse normal stomach by real-time RT-PCR (Supplementary Figure 2) , suggesting that mature miR-7 is processed from all these primary miR-7 in the normal gastric mucosa. MiR-7-1 is located in the intron of the Hnrnpk gene, and a CpG island is found in the promoter region of Hnrnpk (Supplementary Figure  3a) . On the other hand, we could not determine CpG islands that regulate the transcription of miR-7-2 and miR-7b. We thus examined DNA methylation in the CpG islands in the Hnrnpk promoter region. Notably, DNA methylation levels in K19-C2mE gastritis and Gan mouse tumor tissues were not increased compared with the wild-type mouse stomach (Supplementary Figure  3a) . Consistently, DNA methylation was not detected in the promoter region of the HNRNPK gene in human gastric cancer tissues ( Figure 4a ). We also examined the trimethylation of histone H3 at lysine 27 (H3K27me3) in Repression of miR-7 by inflammation D Kong et al the upstream CpG islands of Hnrnpk. However, the H3K27me3 level was not increased in mouse gastritis and gastric tumors compared with the wild-type stomach (Figure 4b ). These results indicate that DNA methylation and trimethylation of H3K27 are not involved in the downregulation of miR-7-1. Moreover, the genomic region including miR-7-1 was not deleted in human gastric cancer cells (Supplementary Figure 3b) , suggesting that miR-7 downregulation in gastric cancer is not caused by genomic deletion. We next examined whether activated macrophages have a role in the downregulation of miR-7, because the major source of proinflammatory cytokines in gastric tumors are macrophages (Oshima et al., 2004 (Oshima et al., , 2011 . To monitor miR-7 activity, reporter vector-transfected cells were used. We confirmed that luciferase activity Repression of miR-7 by inflammation D Kong et al was increased significantly when the miR-7 inhibitor was transfected into reporter vector-transfected Kato-III cells (Supplementary Figure 1c) , indicating that the luciferase reporter system was working. Reporter cells were then treated with the conditioned medium of lipopolysaccharide-stimulated RAW264 cells (CM( þ )) or unstimulated RAW264 cells (CM(À)). Importantly, the luciferase activity increased significantly when cells were stimulated with CM( þ ), whereas the luciferase activity was not changed in control vector-transfected cells (Figure 4c ). Similar results were obtained when CM( þ ) and CM(À) were prepared using mouse intraperitoneal macrophages. These results indicate that activated macrophage-derived factor(s) caused miR-7 downregulation in gastric cancer cells.
To identify macrophage-derived factor(s) that suppress miR-7 expression, reporter cells were stimulated with TNF-a, IL-1b, IL-6 or PGE 2 . However, none of these factors caused an increase in luciferase activity (Supplementary Figure 4) . We thus fractionated CM( þ ) by ultrafiltration, and separated by molecular weight. Interestingly, a CM( þ ) fraction of o3 kDa significantly increased the luciferase activity to a similar level as that induced by whole CM( þ ), whereas the other CM( þ ) fractions did not (Figure 4d) . Moreover, the luciferase activity was still increased when CM( þ ) Repression of miR-7 by inflammation D Kong et al was prepared under co-treatment of RAW264 cells with lipopolysaccharide and a COX-2 inhibitor, celecoxib. We confirmed the decreased level of miR-7 by real-time RT-PCR in CM( þ )-or CM( þ ) fraction o3 kDatreated AZ521 cells (Figure 4e ). These results indicate that small molecule(s) (o3 kDa) derived from activated macrophages are responsible for miR-7 repression in gastric cancer cells, and that such small molecule(s) are expressed in activated macrophages in a COX-2/PGE 2 -independent manner.
Downregulation of miR-7 in the stomach by inflammatory responses
We next examined whether inflammatory responses are responsible for miR-7 downregulation in the stomach using different mouse models. The stomachs of wildtype mice were infected with Helicobacter felis, and submucosal inflammatory infiltration and mucosal macrophage accumulation were confirmed at 20 weeks after the infection (Figures 5a and b) . Notably, the miR-7 expression level was significantly decreased in the H. felis-infected inflamed gastric mucosa (Figure 5c ).
We recently showed that inflammatory responses and macrophage infiltration were suppressed in K19-C2mE mouse gastritis and Gan mouse tumors when mice were maintained under germfree conditions (Figure 5d and Oshima et al., 2011) . Notably, miR-7 expression levels were increased significantly in germfree K19-C2mE and Gan mice compared with the levels of mice maintained in a specific pathogen free (SPF) facility (Figure 5e ). These in vivo experiments suggest that inflammatory responses are responsible for the miR-7 downregulation in the stomach, although further genetic studies are required to examine the role of macrophages in miR-7 downregulation.
Inflammation-dependent upregulation of miR-7 target genes in gastric tumors
The epidermal growth factor receptor (EGFR) mRNA is one of the miR-7 target genes (Kefas et al., 2008; Repression of miR-7 by inflammation D Kong et al Webster et al., 2009) . We thus examined EGFR expression levels in pre-miR-7-transfected Kato-III and AZ521 gastric cancer cells. As expected, the EGFR expression level was decreased significantly by pre-miR-7 transfection in both cell lines (Figure 6a ), suggesting that suppression of EGFR expression is one of the tumor-suppressor mechanisms of miR-7 against gastric cancer development.
To identify novel miR-7 target genes that are upregulated in the inflammatory microenvironment, 
Repression of miR-7 by inflammation
D Kong et al we searched for putative miR-7 target genes from the upregulated gene set in both K19-C2mE mouse gastritis and Gan mouse gastric tumors using the results of the microarray analyses . We found that the Lphn2, Basp1 and Mafg genes have conserved miR-7 target sequences in their 3 0 untranslated region in both mouse and human mRNAs (Figure 6b) . Notably, the expression of these genes was significantly increased not only in K19-C2mE mouse gastritis and Gan mouse tumors but also in K19-Nog/C2mE mouse gastric hamartomas (Figure 6c ). The gastric mucosa and tumors in these strains are inflamed as a result of induction of the COX-2/PGE 2 pathway (Oshima et al., 2004 (Oshima et al., , 2006 , suggesting that downregulation of miR-7 in inflammatory lesions is involved in upregulation of these genes. Notably, transfection of pre-miR-7 into Kato-III cells resulted in a significant decrease of LPHN2, BASP1 and MAFG expressions (Figure 6d ). Moreover, we constructed luciferase reporter plasmids that contained the 3 0 untranslated region fragment of the putative miR-7 target genes, and transfected these vectors into Kato-III cells. Consistent with the real-time RT-PCR results, luciferase activities of reporter vectortransfected cells decreased significantly when cells were co-transfected with pre-miR-7 (Figure 6e ). Taken together, these results indicate that these three genes are miR-7 targets.
Finally, we examined the expressions of LPHN2, BASP1 and MAFG in human gastric cancers by realtime RT-PCR and compared their expressions with miR-7 expression levels. We found that expression levels of miR-7 and LPHN2, BASP1 and MAFG were inversely correlated (Figure 6f ). Accordingly, it is possible that inflammation causes induction of these genes in human gastric cancers through downregulation of miR-7, which may contribute to gastric tumorigenesis, although this will need to be investigated in future studies.
Discussion
It has been shown that miR-155 and miR-21, which function as oncogenes, are induced by inflammatory pathways, providing a link between inflammation and cancer (O'Connell et al., 2007; Tili et al., 2007; Iliopoulos et al., 2010) . Consistently, we found inflammation-dependent induction of miR-155 and miR-21 in mouse gastric tumors. On the other hand, miR-145 and miR-7, which function as tumor suppressors, are downregulated in both mouse gastritis and gastric tumor tissues. Moreover, we found that miR-7 levels are inversely correlated with the levels of proinflammatory cytokines, suggesting that the severity of inflammatory response is related to miR-7 downregulation. Therefore, it is possible that inflammation can promote tumorigenesis both by the upregulation of oncogenic miRNAs and by the downregulation of tumor-suppressor miRNAs, possibly through different mechanisms. Such alterations of cancer-related miRNA expression likely link inflammation and cancer.
It has been reported that miR-7 has a tumorsuppressor role in various cancers including brain tumors, breast cancer and lung cancer (Kefas et al., 2008; Reddy et al., 2008; Webster et al., 2009 ), and we herein showed that miR-7 also functions as a tumor suppressor in gastric cancer. Interestingly, in the normal stomach, miR-7 expression is induced during the differentiation of gastric epithelial cells, suggesting a role of miR-7 in the regulation of epithelial cell differentiation. It has also been reported that miR-7 expression is induced during differentiation of intestinal epithelial cells (Nguyen et al., 2010) and cortical neurons . These results collectively suggest that miR-7 has a role in regulating cell differentiation in various organs. Therefore, it is conceivable that suppression of miR-7 expression is required for maintenance of the undifferentiated status of stem or progenitor cells in these organs.
These results suggest the possibility that inflammation suppresses epithelial cell differentiation through repression of miR-7. It is not surprising that the inflammatory response suppresses cell differentiation and enhances proliferation when regeneration is required in injured tissues. It has also been shown that a disruption of Tolllike receptor signaling causes an impairment of tissue repair by intestinal epithelial cells (Rakoff-Nahoum et al., 2004) . Moreover, activated macrophages are important niche components for intestinal epithelial progenitors in regenerative responses (Pull et al., 2005) . Therefore, it is conceivable that downregulation of miR-7 leads to suppression of differentiation, inducing the proliferation of undifferentiated epithelial cells in the inflammatory microenvironment.
Although several target genes of miR-7 have been identified, it is still unclear how miR-7 regulates differentiation. EGFR is one of the important miR-7 target genes, and is at least partially responsible for its tumor-suppressor role (Kefas et al., 2008) . Moreover, p21-activated kinase 1, Raf1, and the insulin-like growth factor 1 receptor have also been identified as miR-7 target genes that are upregulated in cancer cells (Reddy et al., 2008; Webster et al., 2009; Jiang et al., 2010) . Although most of these gene products contribute to cancer cell proliferation, we believe that miR-7 inhibits expression of other factors that have a role in the maintenance of the undifferentiated status of epithelial cells. In this study, we identified three novel miR-7 target genes that are upregulated in gastric cancers in an inflammation-dependent manner. LPHN2 is a G protein-coupled receptor that binds a-latrotoxin (Ichtchenko et al., 1999), whereas BASP1 is implicated in neurite outgrowth (Korshunova et al., 2008) . MAFG is one of the small Maf proteins that is important for antioxidant responses (Katsuoka et al., 2005) . Although it remains to be investigated, it is of interest to examine whether these molecules have any role in the differentiation or tumorigenesis of gastric epithelial cells.
We examined the mechanisms responsible for miR-7 downregulation in gastric tumor cells. Helicobacter pylori infection induces chronic gastritis, resulting in induction of DNA methylation (Niwa et al., 2010) . The expression of miR-34b/c is suppressed by DNA methylation in H. pylori-associated gastric cancer cells (Suzuki et al., 2010) . Moreover, H3K27me3 leads to tumorsuppressor gene silencing in cancer (Kondo et al., 2008) . However, we showed that downregulation of miR-7 is not caused by genomic deletion nor by epigenetic mechanisms, but through stimulation by macrophagederived factor(s). Several mechanisms for the regulation of miR-7 expression have been reported. For example, miR-7 transcription is directly induced by HoxD10 (Reddy et al., 2008) or c-Myc (Chou et al., 2010) . Splicing factor SF2/ASF binds the pri-miR-7 to enhance its cleavage by Drosha (Wu et al., 2010) . Accordingly, it is conceivable that macrophage-derived molecule(s) directly downregulate miR-7 expression or indirectly suppress miR-7 expression through modulation of these regulation systems. The identification of responsible macrophage-derived molecule(s) will provide a novel mechanism by which macrophages promote tumorigenesis.
In conclusion, we showed that inflammation simultaneously induces upregulation of oncogenic miRNAs and downregulation of tumor-suppressor miRNAs, which promote tumorigenesis. The expression of miR-7 is induced during differentiation of gastric epithelial cells, suggesting a role for miR-7 in the regulation of epithelial cell differentiation. Accordingly, it is possible that the downregulation of miR-7 contributes to suppression of differentiation, resulting in the promotion of gastric tumorigenesis. Moreover, small molecule(s) expressed by activated macrophages are responsible for miR-7 repression, providing a link between inflammation and cancer. Therefore, miR-7 may be useful for devising a new preventive or therapeutic strategy against gastric cancer through the induction of cancer cell differentiation.
Materials and methods
Mouse models
Construction of K19-C2mE and Gan (K19-Wnt1/C2mE) mice was described previously (Oshima et al., 2004 (Oshima et al., , 2006 . In brief, K19-C2mE mice express Ptgs2 and Ptges in gastric epithelial cells, whereas Gan mice express Ptgs2, Ptges and Wnt1. For expression analyses, K19-C2mE mouse gastritis and Gan mouse gastric tumor samples, and wild-type mouse stomach tissues were obtained at 30-40 weeks of age. Germfree mouse colonies were constructed as described previously (Oshima et al., 2011) , and the histology and miR-7 expression were examined at 55 weeks of age (n ¼ 5). H. felis (American Type Culture Collection 49179, ATCC, Manassas, VA, USA) were inoculated at 10 8 per mouse into wild-type mice at 6-8 weeks of age, and the histology and miRNA expression were examined at 20 weeks after infection (n ¼ 6). All animal experiments were carried out according to a protocol approved by the Committee on Animal Experimentation of the Kanazawa University.
Microarray analysis
Total RNA was extracted from mouse stomachs (n ¼ 3) using ISOGEN (Nippon Gene, Tokyo, Japan), pooled with the same genotype mouse RNAs, labeled with Cy3 and hybridized to Mouse miRNA microarray Rel. 12.0 (Agilent Technologies, Santa Clara, CA, USA). The raw data were normalized using the GeneSpring GX software program (Agilent Technologies), and expression levels of miRNAs in gastritis and gastric tumor tissues were compared with those in the wild-type mouse stomach. Transcripts with low signals (less than threefold of the background level) were not used for further analyses. The expression of miRNAs was further examined by real-time RT-PCR using RNA samples independently prepared from a different set of wild-type, K19-C2mE and Gan mice (n ¼ 5 for each genotype).
The results of cDNA microarray data sets of K19-C2mE, Gan and K19-Nog/C2mE mice were deposited into the Gene Expression Omnibus, as accession number GSE16902 , and were searched for the presence of novel miR-7 target genes using the TargetScan 5.1 program (MIT, Cambridge, MA, USA) (http://www.targetscan.org).
Real-time RT-PCR
Paired gastric cancer and non-tumor stomach tissue samples were obtained from 28 patients during surgery at the Kanazawa University Hospital, Japan. Fresh frozen tissues were used for expression analyses. Clinicopathological data of patients are shown in Supplementary Table 3. Human normal gastric epithelial cells were prepared by isolating the gastric glands from normal stomach tissues (n ¼ 4) as described previously (Cheng et al., 1984) . Approval for this project was obtained from the Kanazawa University Medical Ethics Committee, and written informed consent was obtained before specimen collection. Mouse stomachs were obtained from E15 wild-type mouse embryos, and day 0, day 7, day 14 and adult mice (n ¼ 3 for each). Total RNAs were extracted from tissues or cells using ISOGEN (Nippon Gene), and cDNAs for miRNAs and mRNAs were constructed using QuantiMir RT kit (System Bioscience, Mountain View, CA, USA) and the PrimeScript RT reagent Kit (Takara, Tokyo, Japan), respectively. Real-time RT-PCR was performed using SYBR Premix Ex TaqII (Takara, Tokyo, Japan) and Stratagene Mx3000P (Agilent Technologies). Sno202 and U44 were used as endogenous miRNA controls for mice and humans, respectively, whereas b-actin was used for endogenous mRNA control. The primer sequences for the miRNAs are shown in Supplementary Table 4 . The primers for mRNAs were purchased from Takara.
Cell culture experiments
Mouse glandular stomachs were treated with 0.1% collagenase for 30 min at 37 1C, followed by centrifugation at 20 g for 3 min to isolate gastric glands. For the primary culture, isolated gastric glands were digested with trypsin and seeded on collagen-coated dishes as described previously (Oshima et al., 2004) . On day 2, the primary cultured cells were treated with 10 mM EDTA-phosphate-buffered saline and passaged. The primary cultured cells on day 2 (P0) and day 6 (P1) were used for the expression analysis. Human gastric cancer cell lines, AGS (ATCC), AZ521, MKN74, MKN45, NUGC4, HCT-111-TC, SH-10-TC (RIKEN BioResource Center, Tsukuba, Japan), Kato-III and MKN7 (Cell Resource Center for Biomedical Research, Tohoku University, Japan) were used in this study.
The pre-miR miRNA-7 (Pre-miR-7), pre-miR negative control (Pre-miR-NC) and anti-miR-7 inhibitor (Ambion, Austin, TX, USA) were used for transfection. The cell proliferation rate was measured using the Cell Counting Kit-8 (Dojindo, Kumamoto, Japan). For the soft agar colony formation assay, cells were suspended in culture medium with 0.33% agar, and seeded in a 6-well plate. After 21 days of culture, soft agar was stained with Giemsa solution (Wako, Osaka, Japan).
Histological and immunohistochemical analyses
Tissues were fixed in 4% paraformaldehyde, embedded and sectioned at 4-mm thickness. Sections were stained with hematoxylin and eosin. Antibodies against Ki-67 (DakoCytomation, Carpenteria, CA, USA) and F4/80 (Serotec, Oxford, UK) were used as the primary antibodies. Immunostaining signals were visualized using the Vectastain Elite Kit (Vector Laboratories, Burlingame, CA, USA), and the MOM kit (Vector Laboratories) was used to minimize the background staining signals.
Methylation-specific PCR analysis
The methylation status of miR-7-1 in human gastric cancer and non-tumor tissues was examined by methylation-specific PCR analysis as described previously (Yamashita et al., 2008) . Methylation-specific PCR was performed with a primer set specific for the methylated or unmethylated sequence (Me or Un set in Supplementary Table 4) . DNA methylated by SssI methylase (New England Biolabs, Ipswich, MA, USA) and DNA amplified by a GenomiPhi DNA amplification kit (GE Healthcare, Buckinghamshire, UK) were used as methylated and unmethylated controls, respectively.
Chromatin immunoprecipitation analyses
Histone modifications were examined by chromatin immunoprecipitation assay as described previously (Yamashita et al., 2008; Takeshima et al., 2009) . In brief, gastric epithelial cells of wild-type, K19-C2mE and Gan mice (n ¼ 3 for each genotype) were cross-linked with 1% formaldehyde, and sheared chromatin by Bioruptor UCD-250 (Cosmo Bio, Tokyo, Japan). The samples were incubated with an antibody against H3K27me3 (07-449, Millipore, Billerica, MA, USA), and genomic DNA samples were used for the quantitative chromatin immunoprecipitation-PCR analyses. The primer set was designed for the upstream CpG islands of miR-7-1 (Supplementary Table 4 ).
Luciferase reporter assay
Constructions of the miR-7 luciferase reporter vector (miR-7 Luc) and control vector (control Luc) are shown in Supplementary Figure 1 . Luciferase reporter vectors for the LPHN2, BASP1 and MAFG genes were constructed by subcloning 3 0 untranslated region fragments of the respective human genes into the pGL3 plasmid (Promega, Madison, WI, USA). PCR primer sequences for cloning 3 0 untranslated region of the respective genes and amplified fragment lengths are indicated in Supplementary Table 4 . The luciferase activity was measured using a Luciferase Assay System (Promega), and the levels were normalized to the total protein levels detected using the Pierce 660 nm Protein Assay (Thermo Scientific, Yokohama, Japan). RAW264 cells (RIKEN BioResource Center) and mouse intraperitoneal macrophages were stimulated with 10 ng/ml lipopolysaccharide (Sigma, St Louis, MO, USA) for 24 h and the conditioned medium was collected as CM( þ ). The conditioned medium of unstimulated macrophages was collected as CM(À). The conditioned medium of lipopolysaccharide-stimulated and COX-2 inhibitor celecoxibtreated (Pfizer, New York, NY, USA) (10 mM) RAW264 cells was collected as CM( þ /coxib). CM( þ ) was fractionated by ultrafiltration using Centricon Plus-70 (Millipore) to prepare CM( þ ) 4100 kDa, 30-100 kDa, 3-30 kDa and o3 kDa. Cells were stimulated with CM at a 50% concentration.
Western blotting analysis
Cells were transfected with pre-miR-7 or pre-miR-NC, lysed at 24 h after transfection, and 10 mg of protein was separated in 7.5% SDS-polyacrylamide gels. An antibody against EGFR (Cell Signaling Technology, Danvers, MA, USA) was used as the primary antibody. Anti-b-actin (Sigma) was used as an internal control. The ECL detection system (GE Healthcare) was used to detect the signals, and band intensities were quantified using the ImageJ application (NIH, Bethesda, MD, USA).
Statistical analysis
The data were analyzed by the unpaired t-test using the Microsoft Excel software program (Microsoft). A value of Po0.05 was considered to be statistically significant.
